Upstream Bio stock jumps 8% on Phase 2 severe asthma data

Story context

What to watch: This report cites a concrete figure (8%) — compare it against the trailing trend before treating one data point as a turning point.

Latest session change: $UPB +7.07%

Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures come from the published headline or preview. Session moves may include other news and do not establish cause.